FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Balazs Csernus

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Procedures

Physiology

Disorders

Spinal Cord Injuries

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Weihong Pan; Balazs Csernus; Abba J Kastin
Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.
Weihong Pan; Lihua Zhang; Jie Liao; Balazs Csernus; Abba J Kastin
Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI.
Magdolna Kovacs; Andrew V Schally; Balazs Csernus; Rebeca Busto; Zoltan Rekasi; Attila Nagy
Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Balazs Csernus (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2003: Weihong Pan; Balazs Csernus; Abba J Kastin
Upregulation of p55 and p75 receptors mediating TNF-alpha transport across the injured blood-spinal cord barrier.
Journal of molecular neuroscience : MN 2003;21(2):173-84.
2003: Weihong Pan; Lihua Zhang; Jie Liao; Balazs Csernus; Abba J Kastin
Selective increase in TNF alpha permeation across the blood-spinal cord barrier after SCI.
Journal of neuroimmunology 2003;134(1-2):111-7.
2002: Magdolna Kovacs; Andrew V Schally; Balazs Csernus; Rebeca Busto; Zoltan Rekasi; Attila Nagy
Targeted cytotoxic analogue of luteinizing hormone-releasing hormone (LH-RH) only transiently decreases the gene expression of pituitary receptors for LH-RH.
Journal of neuroendocrinology 2002;14(1):5-13.
2001: Artur Plonowski; Andrew V Schally; Miklos Koppan; Attila Nagy; Jose M Arencibia; Balazs Csernus; Gabor Halmos
Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238.
Cancer 2001;92(5):1168-76.
2001: Karoly Szepeshazi; Andrew V Schally; Gabor Halmos; Baodong Sun; Francine Hebert; Balazs Csernus; Attila Nagy
Targeting of cytotoxic somatostatin analog AN-238 to somatostatin receptor subtypes 5 and/or 3 in experimental pancreatic cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2854-61.
2001: Zoltan Rekasi; Andrew V Schally; Artur Plonowski; Tamas Czompoly; Balazs Csernus; Jozsef Varga
Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
The Prostate 2001;48(3):188-99.
2001: Zoltan Rekasi; Jozsef Varga; Andrew V Schally; Artur Plonowski; Gabor Halmos; Balazs Csernus; Patricia Armatis; Kate Groot
Antiproliferative actions of growth hormone-releasing hormone antagonists on MiaPaCa-2 human pancreatic cancer cells involve cAMP independent pathways.
Peptides 2001;22(6):879-86.
2001: Magdolna Kovacs; Andrew V Schally; Balazs Csernus; Zoltan Rekasi
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix down-regulates the mRNA expression of pituitary receptors for LH-RH by counteracting the stimulatory effect of endogenous LH-RH.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(4):1829-34.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.